Eloxx Pharmaceuticals Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Eloxx Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of Eloxx Pharmaceuticals is $0.0. Our model computes the value of Eloxx Pharmaceuticals from reviewing the firm fundamentals such as Shares Owned By Institutions of 37.06 %, current valuation of 30.28 M, and Shares Owned By Insiders of 0.59 % as well as analyzing its technical indicators and probability of bankruptcy.

Eloxx Pharmaceuticals Total Value Analysis

Eloxx Pharmaceuticals is currently estimated to have valuation of 30.28 M with market capitalization of 14.86 M, debt of 13.38 M, and cash on hands of 30.05 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Eloxx Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
30.28 M
14.86 M
13.38 M
30.05 M

Eloxx Pharmaceuticals Asset Utilization

One of the ways to look at asset utilization of Eloxx is to check how much profit was generated for every dollar of assets it reports. Eloxx Pharmaceuticals shows a negative utilization of assets of -0.73 percent, losing $0.007318 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Eloxx Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.

Eloxx Pharmaceuticals Ownership Allocation

The market capitalization of Eloxx Pharmaceuticals is $14.86 Million. 30% of Eloxx Pharmaceuticals outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Eloxx Pharmaceuticals Profitability Analysis

Net Loss for the year was (36.06 M) with profit before overhead, payroll, taxes, and interest of 0.

Eloxx Pharmaceuticals Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding2.2 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Eloxx Pink Sheet

If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope